We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$18.8M
Cap. Flow
+$773K
Cap. Flow %
0.38%
Top 10 Hldgs %
50.6%
Holding
95
New
11
Increased
22
Reduced
17
Closed
12

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$2.05M
2
AMGN icon
Amgen
AMGN
+$966K
3
TDOC icon
Teladoc Health
TDOC
+$933K
4
GDX icon
VanEck Gold Miners ETF
GDX
+$739K
5
PRTA icon
Prothena Corp
PRTA
+$684K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.52M
2
XNCR icon
Xencor
XNCR
+$608K
3
IMGN
Immunogen Inc
IMGN
+$415K
4
ORCL icon
Oracle
ORCL
+$372K
5
BUR icon
Burford Capital
BUR
+$263K

Sector Composition

Rank Sector Weight
1 Healthcare 29.96%
2 Technology 19.82%
3 Communication Services 7.67%
4 Consumer Discretionary 3.77%
5 Financials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JQC icon
26
Nuveen Credit Strategies Income Fund
JQC
$704M
$2.31M 1.14%
415,000
+1,000
+0.2% +$5.42K
AOD
27
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.17M 1.07%
261,500
– –
BIDU icon
28
Baidu
BIDU
$37.7B
$2.03M 1%
+19,250
New +$2.05M
GM icon
29
General Motors
GM
$80.4B
$1.59M 0.78%
35,000
-5,000
-13% -$194K
LFCR icon
30
Lifecore Biomedical
LFCR
$166M
$1.51M 0.74%
284,684
+25,000
+10% +$179K
GDX icon
31
VanEck Gold Miners ETF
GDX
$22.7B
$1.5M 0.74%
47,500
+26,000
+121% +$739K
CSCO icon
32
Cisco
CSCO
$457B
$1.5M 0.74%
30,000
+5,000
+20% +$249K
QCOM icon
33
Qualcomm
QCOM
$155B
$1.44M 0.71%
8,500
– –
OI icon
34
O-I Glass
OI
$1.1B
$1.42M 0.7%
85,750
+2,500
+3% +$39.5K
F icon
35
Ford
F
$58.5B
$1.33M 0.65%
100,000
– –
RVNC
36
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.3M 0.64%
263,372
+6,500
+3% +$38.5K
MRVL icon
37
Marvell Technology
MRVL
$168B
$1.24M 0.61%
17,500
– –
ALT icon
38
CALL
Altimmune
ALT
$552M
$1.23M 0.61%
121,000
+17,000
+16% +$173K
B
39
Barrick Mining
B
$61.5B
$1.21M 0.59%
72,500
– –
TEVA icon
40
Teva Pharmaceuticals
TEVA
$40.8B
$1.2M 0.59%
85,000
+46,000
+118% +$580K
T icon
41
AT&T
T
$159B
$1.14M 0.56%
65,000
-14,000
-18% -$239K
SLV icon
42
iShares Silver Trust
SLV
$28B
$1.14M 0.56%
50,000
– –
BOXX icon
43
Alpha Architect 1-3 Month Box ETF
BOXX
$13.1B
$1.05M 0.52%
9,875
– –
GLD icon
44
PUT
SPDR Gold Trust
GLD
$131B
$1.03M 0.51%
+5,000
New +$960K
ALT icon
45
Altimmune
ALT
$552M
$980K 0.48%
96,225
-19,000
-16% -$193K
META icon
46
Meta Platforms (Facebook)
META
$1.42T
$971K 0.48%
2,000
– –
STEW
47
SRH Total Return Fund
STEW
$1.79B
$889K 0.44%
59,000
– –
BUR icon
48
Burford Capital
BUR
$903M
$878K 0.43%
55,000
-17,750
-24% -$263K
BA icon
49
Boeing
BA
$171B
$849K 0.42%
4,400
+2,400
+120% +$493K
INTC icon
50
Intel
INTC
$455B
$828K 0.41%
18,750
– –
1
2
3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, DCF Advisers held 95 positions worth $203M, up 10% from $184M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers's Q1 2024 filing shows 11 new, 22 increased, 17 reduced and 12 closed positions. Its largest new stake was Baidu: 19,250 shares worth $2.03M. The largest sale was Regeneron Pharmaceuticals, an estimated $1.52M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q1 2024 buy was Baidu: 19,250 shares worth $2.03M.
  • DCF Advisers added most to Amgen in Q1 2024, an estimated $966K increase.
  • DCF Advisers's biggest Q1 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.52M.
  • DCF Advisers fully exited Immunogen Inc in Q1 2024, selling an estimated $415K.
  • DCF Advisers's ten largest holdings make up 51% of its $203M portfolio in Q1 2024.
  • DCF Advisers opened 11 new positions and closed 12 in Q1 2024.
  • DCF Advisers's portfolio value rose 10% quarter-over-quarter to $203M.

Based on DCF Advisers's 13F filing for Q1 2024, filed 15 May 2024.